The methylene tetrahydrofolate reductase (C677T) mutation as a potential risk factor for avascular necrosis in sickle cell disease

Citation
A. Kutlar et al., The methylene tetrahydrofolate reductase (C677T) mutation as a potential risk factor for avascular necrosis in sickle cell disease, HEMOGLOBIN, 25(2), 2001, pp. 213-217
Citations number
14
Categorie Soggetti
Biochemistry & Biophysics
Journal title
HEMOGLOBIN
ISSN journal
03630269 → ACNP
Volume
25
Issue
2
Year of publication
2001
Pages
213 - 217
Database
ISI
SICI code
0363-0269(2001)25:2<213:TMTR(M>2.0.ZU;2-C
Abstract
Avascular necrosis (AVN) of the humeral and femoral heads is a frequent and debilitating complication of sickle cell disease. Some of the risk factors for AVN are alpha -thalassemia and age. Recently, newly discovered thrombo philia mutations have been associated with AVN in patients without sickle c ell disease. We studied the frequency of the thermolabile methylene tetrahy drofolate reductase (MTHFR) variant (C677T) in adult sickle cell patients w ith and without AVN. The frequency of the MTHFR mutation was 35.6% in patie nts with AVN and 12.9% in those without AVN (p = 0.006). These data suggest that the thermolabile MTHFR variant may be a contributing risk factor for AVN in some populations with sickle cell disease.